Since RACK1 has the potential to be a theraputic target in cervical cancer LN metastasis, it is pivotal to reach a method accurately shielding O-GlcNAcylation site of RACK1 to destroy its stabilization. This evidence concerns the gene RACK1 and cervical carcinoma.